Revival uncertain, Which stock to bet on -IT, pharma or consumer stocks?

On the whole, the market still continues to receive net liquidity. In addition to that, there is a fair bit of participation from domestic investors, from retail investors and a combination of all of these things are driving the markets. The momentum in the market or the price levels are pretty much reflective of the earnings growth which companies have been reporting.

For the large cap IT services companies, there is no case for an upside from a pure PE multiple point of view.Analysts believe that a lot of the midcap IT services companies remain interesting plays.Within the overall IT pack, the companies which are doing R&A, engineering and are shifting and transforming the business models to SaaS model are to be looked for.

The pharma represents one of the best growth opportunities from a short, medium and a long-term perspective.Consumer as a space is again very interesting but experts believe that the top rung consumer companies are fairly valued but there are a bunch of smaller consumer companies which look very interesting.

In total pharma both large cap and midcap plays look attractive whereas in consumer and IT stocks, the midcap and smallcap space look very interesting.